Launch of the Versius surgical robotic system in the first public hospital in France
- Argenteuil Hospital near Paris became the first public hospital in France to use Versius to perform minimal access (keyhole) surgery
- This launch follows a major call for tenders which allowed Versius to be selected by Resah, whose purchasing center has more than one billion euros of purchases in France.
CAMBRIDGE, UK – OCTOBER 13, 2020. 12:01 AM (BST). CMR Surgical (CMR) today announced the launch of its Versius® surgical robotic system at Argenteuil Hospital, a leading public health center based near Paris, France. The announcement follows a tender for Versius, which has now been selected as the preferred surgical robotic system for minimal access surgery (MAS) by Resah – one of the industry’s largest public purchasing centers. health, which works with more than 700 audiences. and private non-profit hospitals, health, social and social centers. Today’s news highlights the value of Versius to major healthcare systems around the world and reinforces its role in advancing a new era of accessible and adaptable surgical robotics.
By Vegard Nerseth, CMR Surgical CEO said: “It’s great to be able to introduce Versius to a renowned public center like the Argenteuil hospital. Argenteuil Hospital acquired the system after being selected by Resah, as part of one of the country’s largest tenders, following a competitive process. This means that hundreds of additional hospitals in France are now able to benefit from Versius. “
Argenteuil hospital has acquired its Versius system to support a range of surgical procedures which could be greatly benefited by robotic MAS. These include urological and gynecological surgery.
Dr Hubert Oro, urologist at Argenteuil hospital commented: “We are delighted to announce the introduction of Versius at the Argenteuil hospital. It is a revolutionary technology that provides the precision, versatility and freedom surgeons need during minimal access procedures. In one system, we have all the options we need – we can use a single robotic arm, for an emergency, or have three arms working together to perform a range of complex and time-consuming procedures. In short, Versius adapts completely to our needs and will strengthen our surgical capabilities, allowing us to significantly improve patient care.
Versius brings next generation technology to MAS. It can be easily moved and used in virtually any operating room. It also offers a way to make surgical robotics more available in a systematic way, addressing inequalities in access to surgical robotics technology. Across France, more than 1,500 hospitals currently perform SAMs, but only 6% of medium-sized public hospitals have a robotic surgery department.is Versius aims to offer an innovative solution to this challenge, making MAS much more accessible.
– ENDS –
If you would like to know more, please contact CMR Surgical at:
Sarah Ghabina / Ashley Davis-Marin
Global Communications Manager / Senior Communications Executive, CMR Surgical
T +44 (0) 1223 755801
E [email protected]
Tim Cockroft, akt Health Communications
T +44 (0) 7957 325 583
E [email protected]
Notes to Editors:
About the Resah group call for tenders
The Resah public interest group (GIP) has one of the largest public purchasing groups in France, with 10 purchasing channels covering most of the needs of establishments. It pooled 1.2 billion euros in purchases in 2019. It works with more than 700 establishments throughout France in the health, medico-social and social sector in the area of pooling and professionalization of purchases.
About Versius at Argenteuil Hospital
Versius aims to ensure that surgeons and hospitals are able to provide patients with the highest quality surgical care. At Argenteuil hospital, it has been used to perform a range of procedures in many disciplines. These include urological surgery and gynecological surgery. These procedures are often complex and can take many hours. Using a robotic MAS in these cases can dramatically reduce the physical fatigue of the surgeon, can reduce a patient’s recovery time from weeks to days, and can reduce the risk of surgical site infections – a problem which would cost health services in Europe up to €. 19 billion per year.ii
Argenteuil Hospital treats more than 35,700 patients each year, performing around 6,500 surgeries. While robotic MAS historically has been prohibitively expensive for many hospitals (especially public hospitals). CMR Surgical designed Versius to be versatile and cost effective, available through financial models that provide budget certainty and support consistent use of the system.
The Versius® Surgical robotic system
Versius® resets expectations for robotic surgery. Versius fits into virtually any operating room setup and seamlessly integrates into existing workflows, increasing the likelihood of robotic minimal access (MAS) surgery. Versius’ portable and modular design allows the surgeon to use only the number of arms needed for a given procedure.
Biomimicating the human arm, Versius offers surgeons the choice of optimized port placement as well as the dexterity and precision of small full wrist instruments. With 3D HD vision, easy-to-adopt instrument control and a choice of ergonomic working positions, the open surgeon’s console has the potential to reduce stress and fatigue and allows clear communication with the surgical team. With laparoscopy in mind and operating robotically with Versius, patients, surgeons and healthcare professionals can all benefit from the value robotic MAS brings.
About CMR Surgical Limited
CMR Surgical (CMR) is a global medical device company dedicated to transforming surgery with Versius®, a new generation surgical robot.
Based in Cambridge, UK, CMR is committed to working with surgeons, surgical teams and hospital partners, to provide an optimal tool for making minimum access robotic surgery universally accessible and affordable. With Versius, we are on a mission to redefine the surgical robotics market with practical and innovative technology and data that can improve surgical care.
Founded in 2014, CMR Surgical is a limited liability company backed by a base of international shareholders.
isDr Jean-Claude COUFFINHAL. Report on the professional, HR, organization and population impact of the progressive territorial deployment of surgical robots in CHUs in the Ile-de-France region and outside CHUs. Ile de France regional health agency. June 2019
iiDavid J Leaper et al., Surgical site infection – a European perspective on the incidence of economic burden. International Journal of Wounds. December 2004.